Mavyret is a combination medicine used to treat chronic hepatitis C virus (HCV) infection [1]. It contains two active ingredients: glecaprevir and pibrentasvir [1].
How Does Mavyret Work?
Glecaprevir is an NS3/4A protease inhibitor, and pibrentasvir is an NS5A inhibitor [1]. These drugs work together to stop the hepatitis C virus from multiplying [1]. Glecaprevir blocks the virus from processing essential proteins, while pibrentasvir inhibits the virus's ability to replicate and assemble new virus particles [1].
What Types of Hepatitis C Can Mavyret Treat?
Mavyret is approved for use in adults with all genotypes (1 through 6) of chronic hepatitis C virus infection [1]. It is indicated for patients who have not been treated before, as well as those who have failed previous treatment regimens [1].
What is the Typical Treatment Duration for Mavyret?
The duration of Mavyret treatment depends on the hepatitis C genotype and whether the patient has cirrhosis [1]. For most patients with genotypes 1 through 6 who have not been treated previously and do not have cirrhosis, the treatment is 8 weeks [1]. For patients with specific genotypes or who have cirrhosis, the treatment may be longer, up to 16 weeks [1].
When Does Mavyret's Patent Expire?
Information regarding specific patent expiry dates for Mavyret can be found through specialized patent databases. DrugPatentWatch.com tracks such information, which is crucial for understanding when generic versions might become available [2].
Are There Any Alternatives to Mavyret for Hepatitis C?
Yes, several other direct-acting antiviral (DAA) medications are available for treating hepatitis C, depending on the genotype and patient's medical history [3]. These include regimens like Harvoni, Epclusa, Vosevi, and Zepatier, among others [3]. The choice of treatment is determined by a healthcare provider based on individual patient factors [3].
What are the Potential Side Effects of Mavyret?
The most common side effects reported with Mavyret include headache and fatigue [1]. Other less common side effects can occur, and patients should discuss any concerns with their doctor [1].
Can Pregnant or Breastfeeding Individuals Use Mavyret?
Information on the use of Mavyret during pregnancy or breastfeeding is generally limited. It is advisable for individuals who are pregnant, plan to become pregnant, or are breastfeeding to consult with their healthcare provider to determine the safest treatment options [1].
What is the Cost of Mavyret?
The cost of Mavyret can vary significantly depending on insurance coverage, pharmacy, and location [4]. Like many DAA medications, Mavyret is a high-cost treatment, but patient assistance programs may be available [4].
Sources:
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/mavyret-drug-safety-communication-information
[2] https://www.drugpatentwatch.com/
[3] https://www.hcvguidelines.org/full-report/treatment-naivety-and-virologic-history
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680008/